iSpecimen Inc. Files 8-K Report

Ticker: ISPC · Form: 8-K · Filed: 2025-01-16T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, filing, disclosure

TL;DR

iSpecimen filed an 8-K on Jan 16, 2025, covering other events and financial exhibits.

AI Summary

On January 16, 2025, iSpecimen Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and operational events. No specific financial figures or significant business changes were detailed in the provided excerpt.

Why It Matters

This filing serves as an official notification to the SEC and investors about significant company events or financial updates. It provides transparency regarding iSpecimen Inc.'s operational status.

Risk Assessment

Risk Level: low — The filing is a routine disclosure and does not contain information that inherently increases risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for iSpecimen Inc.?

The filing is a Current Report (Form 8-K) pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting "Other Events" and "Financial Statements and Exhibits" as of January 16, 2025.

When was the earliest event reported in this filing?

The earliest event reported is dated January 16, 2025.

In which state is iSpecimen Inc. incorporated?

iSpecimen Inc. is incorporated in Delaware.

What is the principal executive office address for iSpecimen Inc.?

The principal executive office is located at 8 Cabot Road, Suite 1800, Woburn, MA 01801.

What is the Commission File Number for iSpecimen Inc.?

The Commission File Number for iSpecimen Inc. is 001-40501.

From the Filing

0001213900-25-004256.txt : 20250116 0001213900-25-004256.hdr.sgml : 20250116 20250116170010 ACCESSION NUMBER: 0001213900-25-004256 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250116 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250116 DATE AS OF CHANGE: 20250116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 25536257 BUSINESS ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 8-K 1 ea0227841-8k_ispecimen.htm CURRENT REPORT false 0001558569 0001558569 2025-01-16 2025-01-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of Report (Date of earliest event reported): January 16, 2025   iSpecimen Inc. (Exact name of registrant as specified in its charter)   Delaware   001-40501   27-0480143 (State or other jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)   8 Cabot Road, Suite 1800 Woburn , MA 01801 (Address of principal executive offices, including zip code)   Registrant’s telephone number, including area code: ( 781 ) 301-6700   Not Applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the regis trant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Secur ities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Common Stock, par value $0.0001 per share   ISPC   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company ☒   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐             Item 8.01 Other Events.   On January 16, 2025, iSpecimen Inc. (the “Company”) announced that it has secured suppliers for the flu-like human metapneumovirus (hMPV), positioning itself to address potential specimen demand for studying the disease and developing a vaccine amid growing concerns of a COVID-style pandemic. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.   Item 9.01 Financial Statements and Exhibits.   (d) Exhibits   Exhibit No.   Description 99.1   Press release dated January 16

View on Read The Filing